Method and System for Detection of Disease Patterns

Publication: DE102014112923A1
Published: 2016-03-10
Family Size: 1
Granted: No

Simple SummaryContent extracted from patent full text and abstract with AI.

This invention describes a method and system for detecting diseases by analyzing a sample—especially a body fluid—in vivo using electron spin resonance (ESR) spectroscopy. The system specifically measures the concentration of one or more target components such as ferritin or carbonate radicals, which can be indicative of certain medical conditions.

Use CasesContent extracted from patent full text and abstract with AI.

  • Early and non-invasive detection of diseases based on body fluid analysis
  • Monitoring disease progression or response to treatment via biochemical markers
  • Clinical diagnostics in hospitals or outpatient settings
  • Research into oxidative stress and related biomarkers in medical studies
  • Screening for diseases associated with abnormal ferritin or carbonate radical levels

BenefitsContent extracted from patent full text and abstract with AI.

  • Enables early and precise disease detection using non-invasive methods
  • Provides specific biochemical information that can improve diagnostic accuracy
  • May allow for real-time, in vivo (within the living body) analysis
  • Reduces the need for invasive diagnostic procedures
  • Supports tailored treatment and monitoring by tracking relevant biomarkers

Technical Classifications (CPCs)

Main Classifications

Health, Food & Consumer Tech

Physics & Measurement

Sub Classifications

Measuring & Testing

Medical & Vet Science

CPC Codes

A61B5/055A61B5/14546G01N24/10G01R33/60

Inventors & Applicants

Applicants

Friedrich Alexander Universität Erlangen Nürnberg

Patent Abstract

Die Erfindung bezieht sich auf ein Verfahren und ein System zur Detektion von Krankheitsbildern, bei dem eine Probe (P) mittels Elektronenspinresonanzspektroskopie hinsichtlich einer Konzentration zumindest eines vorgegebenen Bestandteils insbesondere einer Körperflüssigkeit insbesondere in-vivo spektroskopisch analysiert wird, wobei der zumindest eine vorgegebene Bestandteil insbesondere zumindest eines ist von – Ferritin, dessen Konzentration bestimmt wird, und – Karbonatradikal, insbesondere aus einer Reaktion von Peroxynitrit und Kohlenstoffdioxid entstehendem Karbonatradikal, dessen Konzentration bestimmt wird.

Key Information

Publication No.

DE102014112923A1

Family ID

55358313

Publication Date

2016-03-10

Application No.

DE102014112923A

Application Date

2014-09-09

Priority Date

2014-09-09

Granted

No

Possible Cooperation

For further information please contact the transfer office.